Breakthrough trial aims to free hepatitis b patients from lifelong medication
NCT ID NCT05630807
Summary
This large Phase 3 study is testing whether an investigational drug called bepirovirsen can provide a 'functional cure' for people with chronic Hepatitis B. It involves nearly 1,000 participants who are already on standard antiviral medication. The main goal is to see if adding bepirovirsen for 24 weeks can suppress the virus enough that patients can safely stop all treatments and remain healthy long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Chandler, Arizona, 85224, United States
-
GSK Investigational Site
Davis, California, 95817, United States
-
GSK Investigational Site
Los Angeles, California, 90027, United States
-
GSK Investigational Site
Palo Alto, California, 94304, United States
-
GSK Investigational Site
San Jose, California, 95128, United States
-
GSK Investigational Site
Littleton, Colorado, 80120, United States
-
GSK Investigational Site
Miami, Florida, 33134, United States
-
GSK Investigational Site
Iowa City, Iowa, 52242, United States
-
GSK Investigational Site
Baltimore, Maryland, 21287, United States
-
GSK Investigational Site
Detroit, Michigan, 48377, United States
-
GSK Investigational Site
Richmond, Virginia, 23219, United States
-
GSK Investigational Site
Richmond, Virginia, 23249, United States
-
GSK Investigational Site
Buenos Aires, 1061, Argentina
-
GSK Investigational Site
Buenos Aires, C1061AAS, Argentina
-
GSK Investigational Site
Buenos Aires, C1125ABE, Argentina
-
GSK Investigational Site
Capital Federal, C1181ACI, Argentina
-
GSK Investigational Site
Pilar, B1629AHJ, Argentina
-
GSK Investigational Site
Rosario, S2002KDT, Argentina
-
GSK Investigational Site
Aracaju, 49060-010, Brazil
-
GSK Investigational Site
Campinas, 13034-685, Brazil
-
GSK Investigational Site
Curitiba, 80810-050, Brazil
-
GSK Investigational Site
Manaus, 69040-000, Brazil
-
GSK Investigational Site
Porto Alegre, 90035003, Brazil
-
GSK Investigational Site
Santa Maria, 97105-900, Brazil
-
GSK Investigational Site
São Paulo, 05403-000, Brazil
-
GSK Investigational Site
São Paulo, 08270-070, Brazil
-
GSK Investigational Site
Vila Mariana, 04121-000, Brazil
-
GSK Investigational Site
Sofia, 1431, Bulgaria
-
GSK Investigational Site
Sofia, 1606, Bulgaria
-
GSK Investigational Site
Sofia, Bulgaria
-
GSK Investigational Site
Veliko Tarnovo, 5000, Bulgaria
-
GSK Investigational Site
Vancouver, British Columbia, V6Z 2K5, Canada
-
GSK Investigational Site
Victoria, British Columbia, V8V 3M9, Canada
-
GSK Investigational Site
Ottawa, Ontario, K1H 8L6, Canada
-
GSK Investigational Site
Toronto, Ontario, M5G 2C4, Canada
-
GSK Investigational Site
Montreal, Quebec, H2X 0A9, Canada
-
GSK Investigational Site
Montreal, Quebec, H4A 3J1, Canada
-
GSK Investigational Site
Québec, Quebec, G1V 4G2, Canada
-
GSK Investigational Site
Saint-Jérôme, Quebec, J7Z 2V4, Canada
-
GSK Investigational Site
Beijing, 100015, China
-
GSK Investigational Site
Beijing, 100050, China
-
GSK Investigational Site
Beijing, China
-
GSK Investigational Site
Changchun, 130021, China
-
GSK Investigational Site
Chengdu, China
-
GSK Investigational Site
Chongqing, 400042, China
-
GSK Investigational Site
Fuzhou, 350025, China
-
GSK Investigational Site
Guangzhou, 510060, China
-
GSK Investigational Site
Guangzhou, 510515, China
-
GSK Investigational Site
Guangzhou, 510630, China
-
GSK Investigational Site
Hangzhou, 310000, China
-
GSK Investigational Site
Hangzhou, 310003, China
-
GSK Investigational Site
Kunming, 650021, China
-
GSK Investigational Site
Nanjing, 210008, China
-
GSK Investigational Site
Shanghai, 200025, China
-
GSK Investigational Site
Shanghai, 200040, China
-
GSK Investigational Site
Shanghai, 201506, China
-
GSK Investigational Site
Shenyang, 110022, China
-
GSK Investigational Site
Shenzhen, 518023, China
-
GSK Investigational Site
Ürümqi, 830054, China
-
GSK Investigational Site
Wuhan, 430022, China
-
GSK Investigational Site
Xi'an, 710061, China
-
GSK Investigational Site
Zhengzhou, 450000, China
-
GSK Investigational Site
Zhenjiang, China
-
GSK Investigational Site
Clermont-Ferrand, 63003, France
-
GSK Investigational Site
Clichy, 92118, France
-
GSK Investigational Site
Dijon, 21079, France
-
GSK Investigational Site
Lille, 59037, France
-
GSK Investigational Site
Pessac, 33604, France
-
GSK Investigational Site
Poitiers, 86021, France
-
GSK Investigational Site
Rennes, 35033, France
-
GSK Investigational Site
Strasbourg, 67091, France
-
GSK Investigational Site
Toulouse, 31059, France
-
GSK Investigational Site
Berlin, 10243, Germany
-
GSK Investigational Site
Berlin, 10439, Germany
-
GSK Investigational Site
Berlin, 10787, Germany
-
GSK Investigational Site
Berlin, 12163, Germany
-
GSK Investigational Site
Bochum, 44787, Germany
-
GSK Investigational Site
Cologne, 50668, Germany
-
GSK Investigational Site
Düsseldorf, 40225, Germany
-
GSK Investigational Site
München, 80336, Germany
-
GSK Investigational Site
Athens, 10676, Greece
-
GSK Investigational Site
Athens, 11527, Greece
-
GSK Investigational Site
Periohi Dragana Alexand, 68100, Greece
-
GSK Investigational Site
Rio Patras, 26504, Greece
-
GSK Investigational Site
Kowloon, Hong Kong
-
GSK Investigational Site
Pokfulam, Hong Kong
-
GSK Investigational Site
Shatin, Hong Kong
-
GSK Investigational Site
Budapest, 1097, Hungary
-
GSK Investigational Site
Eger, 3300, Hungary
-
GSK Investigational Site
Gyula, 5700, Hungary
-
GSK Investigational Site
Miskolc, 3530, Hungary
-
GSK Investigational Site
Belagavi, 590010, India
-
GSK Investigational Site
Chandigarh, 160012, India
-
GSK Investigational Site
Chennai, 600113, India
-
GSK Investigational Site
Coimbatore, 641005, India
-
GSK Investigational Site
Guhawati, 781006, India
-
GSK Investigational Site
Hyderabad, 500033, India
-
GSK Investigational Site
HyderabadTelangana, 500048, India
-
GSK Investigational Site
Jaipur, 302001, India
-
GSK Investigational Site
Ludhiana, 141001, India
-
GSK Investigational Site
Manipal, 576104, India
-
GSK Investigational Site
Mumbai, 400 008, India
-
GSK Investigational Site
Mumbai, 400012, India
-
GSK Investigational Site
Mumbai, 400026, India
-
GSK Investigational Site
Pune, 411001, India
-
GSK Investigational Site
Surat, 395002, India
-
GSK Investigational Site
Brescia, 25123, Italy
-
GSK Investigational Site
Foggia, 71100, Italy
-
GSK Investigational Site
Messina, 98124, Italy
-
GSK Investigational Site
Milan, 20122, Italy
-
GSK Investigational Site
Milan, 20162, Italy
-
GSK Investigational Site
Modena, 40126, Italy
-
GSK Investigational Site
Chiba, 272-8516, Japan
-
GSK Investigational Site
Ehime, 790-8524, Japan
-
GSK Investigational Site
Fukuoka, 820-8505, Japan
-
GSK Investigational Site
Fukuoka, 839-0863, Japan
-
GSK Investigational Site
Gifu, 500-8717, Japan
-
GSK Investigational Site
Gifu, 503-8502, Japan
-
GSK Investigational Site
Hiroshima, 734-8551, Japan
-
GSK Investigational Site
Hiroshima, 737-0023, Japan
-
GSK Investigational Site
Hokkaido, 053-8506, Japan
-
GSK Investigational Site
Hyōgo, 660-8550, Japan
-
GSK Investigational Site
Kumamoto, 862-8655, Japan
-
GSK Investigational Site
Miyagi, 980-8574, Japan
-
GSK Investigational Site
Tokyo, 113-8519, Japan
-
GSK Investigational Site
Tokyo, 173-8610, Japan
-
GSK Investigational Site
Tokyo, 180-8610, Japan
-
GSK Investigational Site
George Town, Malaysia
-
GSK Investigational Site
Johor Bahru, 80100, Malaysia
-
GSK Investigational Site
Kota Bharu Kelantan, Malaysia
-
GSK Investigational Site
Kota Kinabalu, Malaysia
-
GSK Investigational Site
Kuala Lumpur, Malaysia
-
GSK Investigational Site
Kuantan, Malaysia
-
GSK Investigational Site
Guadalajara, 44160, Mexico
-
GSK Investigational Site
Oaxaca City, 68000, Mexico
-
GSK Investigational Site
Panama City, 07206, Panama
-
GSK Investigational Site
Bytom, 41-902, Poland
-
GSK Investigational Site
Krakow, 31-202, Poland
-
GSK Investigational Site
Łańcut, 37-100, Poland
-
GSK Investigational Site
Bucharest, 021105, Romania
-
GSK Investigational Site
Bucharest, 20125, Romania
-
GSK Investigational Site
Cluj-Napoca, 400162, Romania
-
GSK Investigational Site
Iași, 700116, Romania
-
GSK Investigational Site
Suceava, 720224, Romania
-
GSK Investigational Site
Timișoara, 300001, Romania
-
GSK Investigational Site
Singapore, 119074, Singapore
-
GSK Investigational Site
Singapore, 169608, Singapore
-
GSK Investigational Site
Ansan, 15355, South Korea
-
GSK Investigational Site
Busan, 47392, South Korea
-
GSK Investigational Site
Daegu, 42601, South Korea
-
GSK Investigational Site
Daegu, 700-721, South Korea
-
GSK Investigational Site
Seoul, 03080, South Korea
-
GSK Investigational Site
Seoul, 06351, South Korea
-
GSK Investigational Site
Seoul, 07061, South Korea
-
GSK Investigational Site
Seoul, 08308, South Korea
-
GSK Investigational Site
Barcelona, 08035, Spain
-
GSK Investigational Site
Barcelona, 08036, Spain
-
GSK Investigational Site
León, 24080, Spain
-
GSK Investigational Site
Madrid, 28041, Spain
-
GSK Investigational Site
Málaga, 29010, Spain
-
GSK Investigational Site
Salamanca, 37007, Spain
-
GSK Investigational Site
Santander, 39008, Spain
-
GSK Investigational Site
Valencia, 46014, Spain
-
GSK Investigational Site
Valladolid, 47003, Spain
-
GSK Investigational Site
Vigo, 36002, Spain
-
GSK Investigational Site
Kaohsiung City, 807, Taiwan
-
GSK Investigational Site
Kaohsiung City, 833, Taiwan
-
GSK Investigational Site
Taichung, 40705, Taiwan
-
GSK Investigational Site
Taipei, 104, Taiwan
-
GSK Investigational Site
Tau-Yuan, 333, Taiwan
-
GSK Investigational Site
Bangkok, 10330, Thailand
-
GSK Investigational Site
Ankara, 06230, Turkey (Türkiye)
-
GSK Investigational Site
Birmingham, B15 2TH, United Kingdom
-
GSK Investigational Site
Edinburgh, EH4 2XU, United Kingdom
-
GSK Investigational Site
Leeds West Yorkshire, LS9 7TF, United Kingdom
-
GSK Investigational Site
London, SE5 9RS, United Kingdom
-
GSK Investigational Site
London, SW17 0QT, United Kingdom
Conditions
Explore the condition pages connected to this study.